Furthermore, much of the current knowledge is based on preclinical studies, making it difficult to extrapolate these findings to humans due to inherent differences in disease manifestation, progression, and individual biological responses
For patients with confirmed pernicious anaemia or malabsorption disorders, injectable therapy remains the recommended first-line treatment according to NICE CKS guidance, as oral supplementationregardless of dosecannot reliably correct deficiency in these circumstances
Horovitz regularly writes for The New York Times, The Wall Street Journal, The Washington Post, Investors Business Daily, AARP The Magazine, AARP Bulletin, Kaiser Health News and PBSs Next Avenue .
10.1097/00003086-199305000-00038 59 KawakamiT.KawaiT.TakeiN.KiseT.EdaS.UristM